Search


EMA Guidance: Anonymisation and Confidentiality in Risk Management Plans (RMPs)
The European Medicines Agency (EMA)Â has published a revised guideline titled " Guidance on the Anonymisation of Protected Personal Data...

Sharan Murugan
Apr 184 min read
23 views
0 comments


EMA Guidance: Procedural Advice on Paediatric Applications
The European Medicines Agency (EMA) has issued updated guidance " Procedural advice on Paediatric Applications " to support stakeholders...

Sharan Murugan
Apr 183 min read
25 views
0 comments


UK MHRA Guidance: Risk Minimisation Measures for Medicines
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has published updated guidance on " Risk Minimisation Measures (RMMs)Â for...

Sharan Murugan
Apr 182 min read
15 views
0 comments


SAHPRA Guideline: Section 21 Access to Unregistered Medicines
The South African Health Products Regulatory Authority (SAHPRA)Â has updated its Guideline " Section 21 Access to Unregistered Medicines "...

Sharan Murugan
Apr 63 min read
73 views
0 comments


Swissmedic’s Guidance: Packaging, Prior Notification Procedures, Fast-Track Authorisation, Regulatory Meetings & Temporary Authorisations
Swissmedic, the Swiss Agency for Therapeutic Products, has released multiple updated guidance documents in April 2025 that impact...

Sharan Murugan
Apr 62 min read
16 views
0 comments


EMA’s Reflection Paper: Linking to ePI from EU Medicine Packages – A Digital Leap in Patient Information
The European Medicines Agency (EMA) published on 31 March 2025 a draft " Reflection paper on linking to electronic Product Information...

Sharan Murugan
Apr 54 min read
35 views
0 comments


UK MHRA Guidance: National Assessment Procedure for Medicines, Submission and Assessment timetables for Innovative Medicines Applications
The Medicines and Healthcare Products Regulatory Agency (MHRA)Â has introduced a " National Assessment Procedure for Medicines " Â for...

Sharan Murugan
Apr 32 min read
61 views
0 comments


UK MHRA Guidance: Periodic Safety Update Reports (PSURs) for Medicinal Products
Ensuring the ongoing safety and efficacy of medicinal products is a cornerstone of pharmacovigilance. In the United Kingdom, the...

Sharan Murugan
Apr 13 min read
63 views
0 comments


UK MHRA: Guidance for Established Medicines -Marketing Authorisation Application Changes
The regulatory landscape for pharmaceuticals is constantly evolving, and the UK Medicines and Healthcare products Regulatory Agency...

Sharan Murugan
Apr 12 min read
24 views
0 comments


EMA's New AI Work Plan: Shaping the Future of Medicines Regulation
The European Medicines Agency (EMA) has unveiled a comprehensive Artificial Intelligence (AI) Work Plan  to guide the integration of AI...

Sharan Murugan
Mar 312 min read
37 views
0 comments


USFDA Guidance: Study Data Technical Conformance Guide – Technical Specifications Document and Data Standards Catalog
The U.S. Food and Drug Administration (FDA) has released the latest version (v6.0) of the Study Data Technical Conformance Guide in...

Sharan Murugan
Mar 303 min read
89 views
0 comments


UK MHRA Guidance: Blue Guide -Advertising and Promoting Medicines – A Regulatory Overview
The UK Medicines and Healthcare Products Regulatory Agency (MHRA)Â has updated the Appendix 4 Best Practice Guidance of the " Blue Guide:...

Sharan Murugan
Mar 302 min read
41 views
0 comments


MHRA Guidance: Registering to Manufacture, Import, or Distribute Active Substances
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has established guidelines " Medicines: Register to manufacture, import...

Sharan Murugan
Mar 262 min read
34 views
0 comments


USFDA Announcement: Facility Fee Rates for OTC Monograph Drug User Fee Program (OMUFA) for FY 2025
The U.S. Food and Drug Administration (FDA)Â has announced the release of " Over-the-Counter Monograph Drug User Fee Program-Facility Fee...

Sharan Murugan
Mar 212 min read
95 views
2 comments


EMA User Guide: For Micro, Small, and Medium-Sized Enterprises (SMEs)
The European Medicines Agency (EMA)Â has released a " User Guide for Micro, Small, and Medium-Sized Enterprises (SMEs) "Â to help...

Sharan Murugan
Mar 182 min read
26 views
0 comments


SAHPRA Regulatory Information Management System (RIMS): Cancellation of Health Product Registrations for Non-eCTDs
The South African Health Products Regulatory Authority (SAHPRA)Â has issued a Communication to the industry " Regulatory Information...

Sharan Murugan
Mar 162 min read
28 views
0 comments


EMA IRIS Guide for Applicants: A Comprehensive Overview
The European Medicines Agency (EMA)Â has released the updated " IRIS Guide for Applicants , " which provides detailed instructions on how...

Sharan Murugan
Mar 163 min read
50 views
0 comments


MHRA Guidance: Good Clinical Practice (GCP) for Clinical Trials
The Medicines and Healthcare Products Regulatory Agency (MHRA)Â has released updated guidance on " Good Clinical Practice (GCP)Â for...

Sharan Murugan
Mar 153 min read
25 views
0 comments


UK MHRA: Guidance on Regulation and Licensing of Advanced Therapy Medicinal Products (ATMPs) in the UK
To legally sell or supply an Advanced Therapy Medicinal Product (ATMP) in the United Kingdom, you must obtain a marketing authorisation...

Sharan Murugan
Mar 92 min read
48 views
0 comments


Swissmedic Guidance: Renewal, Discontinuation, and Status Change of Medicinal Product Authorizations
The Swiss Agency for Therapeutic Products (Swissmedic)Â has released an updated guidance, " Renewal, Discontinuation, and Status Change of...

Sharan Murugan
Mar 32 min read
28 views
0 comments